Selegiline (SEL, L-deprenyl), a monoamine oxidase-B (MAO-B) inhibitor, is a useful anti-Parkinson drug both in monotherapy and as an adjunct to levodopa therapy [6]–[8]. Here, MAOB is linked to Parkinsonism.